AI heart tracing tests to spot aortic stenosis and diastolic dysfunction in clinic patients
Tests AI-reading of heart tracings for aortic stenosis and diastolic dysfunction in outpatients.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 8 Nov 2024
- Expected to end
- Mar 2027
- Type of study
- Observational
- Treatments tested
- AI-ECG Dashboard
- Point of care ultrasound (POCUS)
- Record updated
- 4 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 60 or older who already have an ECG (heart tracing) scheduled as part of their outpatient care. An AI tool reads the ECG to look for aortic stenosis (a narrowed heart valve) and diastolic dysfunction (a stiff heart that fills poorly). People with a positive AI result then get a quick bedside ultrasound.
- Age
- 60 years or older
- Sex
- All sexes
Main reasons for not taking part
- Younger than 59 years
- Not scheduled for a clinical ECG
- Unable to give consent
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- ≥ 60 years of age must have a clinical scheduled ECG performed
Who cannot take part
- < 59 years of age
- Is not scheduled for a clinical ECG
- Unable to provide consent
Where in United States
- Mayo ClinicRochester, United StatesContact: Jae Oh, M.D.Taking people
About the trial
What the trial wants to find out
Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.
The group in the trial
- Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.
Treatment: AI-ECG Dashboard and Point of care ultrasound (POCUS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Clinical Utility of Artificial Intelligence-enabled Electrocardiograms in the Outpatient Practice - Diagnosing Aortic Stenosis and Diastolic Dysfunction
- Plain-language title
- AI heart tracing tests to spot aortic stenosis and diastolic dysfunction in clinic patientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 4 March 2026